Key facts
- This page summarizes Mark Stolper's Form 4 filing for Oncology Institute, Inc. (TOI).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 09 Jul 2026, 16:30.
Mark Stolper - 07 Jul 2026 Form 4 Insider Report for Oncology Institute, Inc. (TOI)
- Reporting relationship
- Director
- Issuer ticker
- TOI
- Reported as of
- 07 Jul 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 09 Jul 2026, 16:30:01 UTC
- Prior SEC filing
- 05 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Mark Hueppelsheuser, Attorney-in-fact for Mark Stolper
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Mark Stolper filed Form 4 for Oncology Institute, Inc. (TOI) on 09 Jul 2026.
Change
- Previous filing in this sequence was filed on 05 Mar 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001281961
Primary reporting owner
STOLPER MARK
- Relationship
- Director
- Address
- 18000 STUDEBAKER ROAD, SUITE 800, CERRITOS
- Signature
- /s/ Mark Hueppelsheuser, Attorney-in-fact for Mark Stolper
- Signature date
- 09 Jul 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TOI
transaction
Common Stock
Award
- Transaction value
- Shares
- +25,833
- Change %
- Price
- $0.000000*
- Shares after
- 25,833
- Date
- 07 Jul 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Represents RSU award that was fully vested upon grant.